Income Statement - MoonLake Immunotherapeutics (MLTX)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | |
|---|---|---|---|---|---|---|
| Total revenue | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Cost of revenue | 2.62 | 1.38 | 0.01 | 0.01 | 0.00 | |
| Gross profit | -2.62 | -1.38 | -0.01 | -0.01 | 0.00 | |
| Total operating expenses | 242.22 | 143.09 | 54.12 | 65.06 | 4.57 | 0.11 |
| Operating income | -244.83 | -143.09 | -54.12 | -65.06 | -4.57 | -0.11 |
| Non-operating income (net) | 15.12 | 22.13 | 10.14 | 0.59 | 0.03 | 0.01 |
| Income before tax | -229.71 | -120.96 | -43.98 | -64.47 | -4.54 | -0.09 |
| Income tax expense | 0.61 | 0.28 | 0.09 | 0.04 | 0.01 | -0.21 |
| Net income | -227.32 | -118.94 | -36.01 | -64.51 | -4.54 | -0.09 |
Show Quarterly Income Statement
Income Statement - MoonLake Immunotherapeutics (MLTX)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | 0.00 | 0.00 | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Cost of revenue | 0.85 | 0.75 | 0.75 | 0.74 | 0.38 | 0.05 | 0.03 | 0.03 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Gross profit | -0.85 | -0.75 | -0.75 | -0.74 | -0.38 | 0.05 | -0.03 | -0.03 | -0.02 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Total operating expenses | 69.18 | 64.47 | 71.43 | 59.96 | 47.49 | 49.58 | 43.08 | 30.58 | 19.82 | 15.03 | 12.98 | 13.19 | 12.93 | 16.70 | 14.77 | 17.65 | 15.94 | 14.27 | 6.27 | 32.68 | 0.09 | 0.10 |
| Operating income | -70.02 | -65.22 | -71.43 | -60.70 | -47.49 | -49.58 | -43.11 | -30.58 | -19.82 | -15.03 | -12.98 | -13.19 | -12.93 | -16.70 | -14.77 | -17.65 | -15.94 | -14.28 | -6.27 | -32.68 | -0.09 | -0.10 |
| Non-operating income (net) | 0.94 | 2.45 | 0.86 | 4.74 | 7.08 | 3.23 | 7.09 | 5.90 | 5.92 | 7.19 | 1.39 | 0.84 | 0.72 | 0.24 | 0.04 | 0.25 | 0.07 | -0.04 | -0.02 | 0.00 | 0.02 | 0.01 |
| Income before tax | -69.09 | -62.77 | -70.58 | -55.96 | -40.41 | -46.35 | -36.02 | -24.68 | -13.91 | -7.84 | -11.59 | -12.34 | -12.21 | -16.46 | -14.73 | -17.41 | -15.87 | -14.31 | -6.29 | -32.69 | -0.08 | -0.09 |
| Income tax expense | 0.62 | 0.25 | 0.12 | 0.10 | 0.15 | 0.04 | 0.09 | 0.08 | 0.07 | 0.04 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | -0.06 | ||
| Net income | -69.71 | -62.43 | -69.73 | -55.22 | -39.94 | -45.60 | -35.39 | -24.27 | -13.67 | -7.44 | -9.43 | -10.14 | -9.00 | -1.94 | -10.11 | -12.12 | -15.88 | -14.32 | -6.29 | -32.69 | -0.08 | -0.09 |